Nancy Lynn Snyderman MD
Director · 2 filings · Latest: Aug 3, 2026
Alkermes plc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALKS | Nancy Lynn Snyderman MD | Director | Aug 3, 2026 | Sale | $50.35 | 44,472 | $2.2M | 15,395 | |
ALKS | Nancy Lynn Snyderman MD | Director | Aug 3, 2026 | Option Exercise | $46.72 | 44,472 | $2.1M | 59,867 | |
ALKS | snyderman nancy lynn MD | — | Aug 3, 2026 | Proposed Sale | $50.35 | 44,472 | $2.2M | — | |
ALKS | Nancy Lynn Snyderman MD | Director | May 21, 2026 | Option Exercise | — | 6,142 | — | 16,870 |